LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 73.00 | 17.25 | 10589 | 5546 | 1.9090 | 1.1615 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 74.97 | 17.25 | 83 | 5618 | 0.0148 | 0.2071 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 74.97 | 17.25 | 11055 | 5618 | 1.9675 | 1.1689 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 74.97 | 17.25 | 121 | 5618 | 0.0215 | 0.2628 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 74.97 | 17.25 | 11019 | 5618 | 1.9611 | 1.1681 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 76.94 | 17.25 | 67 | 5681 | 0.0118 | 0.1761 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 76.94 | 17.25 | 11434 | 5681 | 2.0124 | 1.1744 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 76.94 | 17.25 | 118 | 5681 | 0.0208 | 0.2585 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 76.94 | 17.25 | 11338 | 5681 | 1.9955 | 1.1722 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 78.91 | 17.25 | 90 | 5730 | 0.0157 | 0.2180 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 78.91 | 17.25 | 11686 | 5730 | 2.0392 | 1.1776 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 78.91 | 17.25 | 113 | 5730 | 0.0197 | 0.2516 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 78.91 | 17.25 | 11660 | 5730 | 2.0347 | 1.1770 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 80.88 | 17.25 | 82 | 5826 | 0.0141 | 0.2039 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 80.88 | 17.25 | 11863 | 5826 | 2.0362 | 1.1767 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 80.88 | 17.25 | 114 | 5826 | 0.0196 | 0.2521 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 80.88 | 17.25 | 11915 | 5826 | 2.0451 | 1.1778 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 82.85 | 17.25 | 83 | 5861 | 0.0142 | 0.2054 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 82.85 | 17.25 | 12115 | 5861 | 2.0668 | 1.1804 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 82.85 | 17.25 | 105 | 5861 | 0.0179 | 0.2396 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 82.85 | 17.25 | 12205 | 5861 | 2.0822 | 1.1823 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 84.82 | 17.25 | 86 | 5924 | 0.0145 | 0.2101 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 84.82 | 17.25 | 12372 | 5924 | 2.0884 | 1.1827 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 84.82 | 17.25 | 90 | 5924 | 0.0152 | 0.2167 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 84.82 | 17.25 | 12423 | 5924 | 2.0970 | 1.1838 | MN20160310_N02 | E21 |